• News
  • Podcast
  • Biotech Bulletin
  • Careers
TALG®
  • About
  • Our Team
  • Practice Areas
  • Industries Served
  • Contact
Select Page
FDA Issues NDA and BLA Recommendations Warranting RTOR

FDA Issues NDA and BLA Recommendations Warranting RTOR

by Ismail Amin | Jul 25, 2022 | Biotech Bulletin, News

FDA issues guidance and recommendations for New Drug Applications (NDA) and Biologic Laboratory Applications (BLA) which implicate oncology therapies and warrant Real time Oncology Review (RTOR). On July 25, 2022, the FDA, by and through the Oncology Center for...
Next Entries »
  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
© 2023 TALG® • Privacy Policy • Terms & Conditions - The information provided on this site is not legal advice and does not constitute an attorney-client relationship.